Avita Medica's ReCell Technology To Be Used By U.S. Department of Defense

Avita Medical (ASX:AVH) announces that the U.S. Department of Defense would like to use its innovative ReCell technology burn treatment.
According to the press release:

The July/August 2015 issue of Army Technology Magazine, in an article titled “Innovative treatments offer hope for burn victims,” explored new strategies being evaluated by the Armed Forces Institute of Regenerative Medicine. The Fort Detrick, Maryland-based group has a stated goal to resolve if regenerative medicine — with its potential to use a patient’s own repair mechanisms — can be used to heal traumatic wounds faster, and reduce scarring, contractures and disability amongst U.S. military personnel.
The article explained how Avita Medical’s device took only 30 minutes to use a patient’s own cells to create a healing suspension, which can treat a skin wound 80 times larger than the skin sample taken. The device was one of two regenerative medicine technologies covered in the article, which explained that “ReCell speeds the healing process, decreases the need to harvest skin from donor sites and improves the appearance of the burn scars.”

Click here to read the full press release from Avita Medical.